All serum tumor markers analyzed, including carcinoembryonic antigen (CEA), carbohydrate antigen 19–9 (CA19-9), cancer antigen 125 (CA125), and cancer antigen 15–3 (CA15-3), were found to be within normal ranges prior to treatment. This evidence concerns the gene CEACAM5 and neoplasm.